123 related articles for article (PubMed ID: 32906146)
21. Evaluation of the practicability of a finger-stick whole-blood SARS-Cov-2 self-test adapted for the general population.
Prazuck T; Phan Van J; Sinturel F; Levray F; Elie A; Camera D; Pialoux G
PLoS One; 2021; 16(1):e0245848. PubMed ID: 33508007
[TBL] [Abstract][Full Text] [Related]
22. Roadmap to the Bioanalytical Testing of COVID-19: From Sample Collection to Disease Surveillance.
Hosseini A; Pandey R; Osman E; Victorious A; Li F; Didar T; Soleymani L
ACS Sens; 2020 Nov; 5(11):3328-3345. PubMed ID: 33124797
[TBL] [Abstract][Full Text] [Related]
23. The risk of over-diagnosis in serological testing. Implications for communications strategies.
Biggeri A; Forni S; Braga M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):184-192. PubMed ID: 33412809
[TBL] [Abstract][Full Text] [Related]
24. Efficient Microfluidic-Based Air Sampling/Monitoring Platform for Detection of Aerosol SARS-CoV-2 On-site.
Xiong H; Ye X; Li Y; Qi J; Fang X; Kong J
Anal Chem; 2021 Mar; 93(9):4270-4276. PubMed ID: 33635067
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 antibody tests: statistical implications.
Kankam HK; Hourston GJ; Ravindran P; Azhar B; Pope C
Br J Hosp Med (Lond); 2020 Nov; 81(11):1-5. PubMed ID: 33263485
[TBL] [Abstract][Full Text] [Related]
26. Quantification of the Tradeoff between Test Sensitivity and Test Frequency in a COVID-19 Epidemic-A Multi-Scale Modeling Approach.
Forde JE; Ciupe SM
Viruses; 2021 Mar; 13(3):. PubMed ID: 33799660
[TBL] [Abstract][Full Text] [Related]
27. A word of caution in interpreting COVID-19 diagnostics tests.
Silva SJRD; Pena LJ
J Med Virol; 2021 Feb; 93(2):717-718. PubMed ID: 32949173
[No Abstract] [Full Text] [Related]
28. A robust pooled testing approach to expand COVID-19 screening capacity.
Bish DR; Bish EK; El-Hajj H; Aprahamian H
PLoS One; 2021; 16(2):e0246285. PubMed ID: 33556129
[TBL] [Abstract][Full Text] [Related]
29. Mass population screening for SARS-CoV-2 and false positives-why Liverpool shows we have a problem.
Cook D
BMJ; 2020 Dec; 371():m4954. PubMed ID: 33384318
[No Abstract] [Full Text] [Related]
30. Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers.
Kumleben N; Bhopal R; Czypionka T; Gruer L; Kock R; Stebbing J; Stigler FL
Public Health; 2020 Aug; 185():88-90. PubMed ID: 32590234
[TBL] [Abstract][Full Text] [Related]
31. Performance of Nucleic Acid Amplification Tests for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Prospectively Pooled Specimens.
Wang H; Hogan CA; Miller JA; Sahoo MK; Huang C; Mfuh KO; Sibai M; Zehnder J; Hickey B; Sinnott-Armstrong N; Pinsky BA
Emerg Infect Dis; 2021 Jan; 27(1):92-103. PubMed ID: 33183494
[TBL] [Abstract][Full Text] [Related]
32. Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP.
Bokelmann L; Nickel O; Maricic T; Pääbo S; Meyer M; Borte S; Riesenberg S
Nat Commun; 2021 Mar; 12(1):1467. PubMed ID: 33674580
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of SARS-CoV-2: A Review on the Current Scenario and Future Outlook.
Priyanka ; Choudhary OP; Singh I
Acta Virol; 2020; 64(4):396-408. PubMed ID: 32985200
[TBL] [Abstract][Full Text] [Related]
34. Community Coronavirus Disease 2019 Activity Level and Nursing Home Staff Testing for Active Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Indiana.
Blackburn J; Weaver L; Cohen L; Menachemi N; Rusyniak DE; Unroe KT
J Am Med Dir Assoc; 2021 Jan; 22(1):204-208.e1. PubMed ID: 33248030
[TBL] [Abstract][Full Text] [Related]
35. Multiplexed and Extraction-Free Amplification for Simplified SARS-CoV-2 RT-PCR Tests.
Byrnes SA; Gallagher R; Steadman A; Bennett C; Rivera R; Ortega C; Motley ST; Jain P; Weigl BH; Connelly JT
Anal Chem; 2021 Mar; 93(9):4160-4165. PubMed ID: 33631932
[TBL] [Abstract][Full Text] [Related]
36. Thoracic imaging tests for the diagnosis of COVID-19.
Salameh JP; Leeflang MM; Hooft L; Islam N; McGrath TA; van der Pol CB; Frank RA; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Damen JA; Wang J; ; McInnes MD
Cochrane Database Syst Rev; 2020 Sep; 9():CD013639. PubMed ID: 32997361
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
[TBL] [Abstract][Full Text] [Related]
38. Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks.
Kost GJ
Arch Pathol Lab Med; 2020 Oct; 144(10):1166-1190. PubMed ID: 32298139
[TBL] [Abstract][Full Text] [Related]
39. Evaluating a SARS-CoV-2 screening strategy based on serological tests.
Baccini M; Mattei A; Rocco E; Vannucci G; Mealli F
Epidemiol Prev; 2020; 44(5-6 Suppl 2):193-199. PubMed ID: 33412810
[TBL] [Abstract][Full Text] [Related]
40. Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
Kivelä JM; Jarva H; Lappalainen M; Kurkela S
J Med Virol; 2021 Mar; 93(3):1256-1258. PubMed ID: 33079392
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
